APA (7th ed.) Citation

S, P., & CL, S. (2008). Aromatase inhibitor-associated bone loss: Clinical considerations. Drugs, 68(18), 2591. https://doi.org/10.2165/0003495-200868180-00005

Chicago Style (17th ed.) Citation

S, Pant, and Shapiro CL. "Aromatase Inhibitor-associated Bone Loss: Clinical Considerations." Drugs 68, no. 18 (2008): 2591. https://doi.org/10.2165/0003495-200868180-00005.

MLA (9th ed.) Citation

S, Pant, and Shapiro CL. "Aromatase Inhibitor-associated Bone Loss: Clinical Considerations." Drugs, vol. 68, no. 18, 2008, p. 2591, https://doi.org/10.2165/0003495-200868180-00005.